| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| ABVX | Abivax SA - ADR | 2.45% | 359,305 | $30,504,995 | 359,305 | New | $84.9 | 13F |
| SABS | SAB Biotherapeutics Inc | 1.85% | 11,420,000 | $22,954,200 | 11,420,000 | New | $2.01 | 13F |
| DNTH | Dianthus Therapeutics Inc | 1.12% | 353,998 | $13,929,821 | 353,998 | New | $39.35 | 13F |
| LBRX | LB Pharmaceuticals Inc | 1.02% | 800,000 | $12,632,000 | 800,000 | New | $15.79 | 13F |
| CAMP | CAMP4 Therapeutics Inc | 0.95% | 3,921,568 | $11,764,704 | 3,921,568 | New | $3 | 13F |
| PEPG | Pepgen Inc | 0.86% | 2,325,000 | $10,741,500 | 2,325,000 | New | $4.62 | 13F |
| EPRX | Eupraxia Pharmaceuticals Inc | 0.64% | 1,350,000 | $7,965,000 | 1,350,000 | New | $5.9 | 13F |
| MNPR | Monopar Therapeutics Inc | 0.59% | 90,500 | $7,391,135 | 90,500 | New | $81.67 | 13F |